New pill aims to slash bad cholesterol in High-Risk patients
NCT ID NCT06834932
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 29 times
Summary
This study tests an experimental oral drug, AZD0780, to see if it safely lowers LDL (bad) cholesterol in people with dyslipidaemia. About 432 adults in China will take the drug or a placebo daily for up to 52 weeks. The goal is to measure how well the drug reduces cholesterol levels and to check for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSLIPIDAEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Baotou, 14010, China
-
Research Site
Beijing, 100029, China
-
Research Site
Beijing, 100050, China
-
Research Site
Bengbu, 233004, China
-
Research Site
Changchun, 130021, China
-
Research Site
Changchun, 130033, China
-
Research Site
Changde, 415000, China
-
Research Site
Changsha, 410015, China
-
Research Site
Changzhou, 272100, China
-
Research Site
Chengdu, 610000, China
-
Research Site
Chongqing, 402260, China
-
Research Site
Daqing, 163000, China
-
Research Site
Deyang, 618000, China
-
Research Site
Guangzhou, 510100, China
-
Research Site
Guangzhou, 510220, China
-
Research Site
Hengyang, 421001, China
-
Research Site
Heze, 274099, China
-
Research Site
Linhai, 317000, China
-
Research Site
Luoyang, 471000, China
-
Research Site
Nanchang, 330009, China
-
Research Site
Nanchong, 637900, China
-
Research Site
Nanjing, 210009, China
-
Research Site
Pingxiang, 337055, China
-
Research Site
Qiqihar, 161000, China
-
Research Site
Sanya, 572000, China
-
Research Site
Shanghai, 200032, China
-
Research Site
Shanghai, 200120, China
-
Research Site
Shanghai, 310000, China
-
Research Site
Shenyang, 110004, China
-
Research Site
Shenyang, 110016, China
-
Research Site
Siping, 136000, China
-
Research Site
Taiyuan, 030024, China
-
Research Site
Tianjin, 300457, China
-
Research Site
Wuhan, 430010, China
-
Research Site
Wuhan, 430030, China
-
Research Site
Wuhan, 430060, China
-
Research Site
Xi'an, 710068, China
-
Research Site
Xianyang, 750004, China
-
Research Site
Yinchuan, 750004, China
-
Research Site
Zigong, 643021, China
-
Research Site
Hong Kong, 999077, Hong Kong
-
Research Site
Hong Kong, Hong Kong
-
Research Site
Shatin, 00000, Hong Kong
Conditions
Explore the condition pages connected to this study.